# An Open-Label Study of N-Acetyl Cysteine in Children With Autism

> **NCT00676195** · PHASE2 · COMPLETED · sponsor: **Stanford University** · enrollment: 24 (actual)

## Conditions studied

- Autistic Disorder

## Interventions

- **DRUG:** N-Acetyl Cysteine

## Key facts

- **NCT ID:** NCT00676195
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00676195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00676195, "An Open-Label Study of N-Acetyl Cysteine in Children With Autism". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT00676195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*